Mesa Laboratories, Inc. Appoints David B. Perez as Director
January 25, 2019 at 03:29 am IST
Share
Effective January 23, 2019, Mesa Laboratories, Inc.’s board of directors, upon the recommendation of the nominating and governance committee, appointed David B. Perez (the retiring President and Chief Executive Officer of Terumo BCT) to fill the remaining term of the director vacancy of the recently deceased H. Stuart Campbell. Mr. Perez has not been appointed to any committees at this time and he will hold his office until the next election of Directors by the company’s shareholders (approximately November 2019) or until his earlier resignation or removal.
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
MESA LABORATORIES, INC. 
